Ustekinumab Is Effective for the Treatment of Chronic Antibiotic-Refractory Pouchitis.

Jacob E OllechDavid T RubinLaura GlickRoni WeisshofKatia El JurdiAmanda IsraelNoa Krugliak ClevelandNeil HymanAtsushi SakurabaJoel PekowRussell D CohenSushila R Dalal

Published in: Digestive diseases and sciences (2019)

This is the largest study of ustekinumab treatment for patients with chronic antibiotic-refractory pouchitis. We found that ustekinumab therapy led to the improvement in clinical and endoscopic endpoints.

Keyphrases

stem cells
ulcerative colitis